Business Model Validation : Article

29 results found

Filter Options
The secret to FDA approval, and other insights, from a med tech CEO
Christina Sherwood
5/14/2013
Blog Resource
Summary:

Lisa Earnhardt, president and CEO of Intersect ENT, shares tips on finding your customer, working with physicians, and collaborating with the FDA.

Read More
Translational Medicine Alliance uncovers opportunities for life science entrepreneurs
Christina Sherwood
5/9/2013
Blog Resource
Summary:

Because significant funding is needed to develop new, innovative life science and digital health products and tools, fewer ideas are making the leap from research institutions to product development teams. This clash between the short-term, earnings-driven needs of the medical marketplace and the risky, lengthy, and capital-intensive process of bringing medical ideas to fruition is a major challenge facing modern medicine.

Read More
How life science companies can find – and exploit – the needs of the marketplace
Christina Sherwood
5/7/2013
Blog Resource
Summary:

Dinu Sen, CEO of Amplyx Pharmaceuticals, offers tips on finding need in the sector, hiring, and determining whether working with an accelerator is right for your company.

Read More
Paul Sonnier: Founder of LinkedIn’s 17,000-member Digital Health group
Christina Sherwood
4/23/2013
Blog Resource
Summary:

As head of digital health strategy for the consulting firm Popper and Company, Paul Sonnier helps entrepreneurs develop and commercialize their products. He’s also a mentor for the accelerator Blueprint Health and founder of the Digital Health group on LinkedIn, which boasts nearly 17,000 members.

Read More
LUMO: Co-founder shares tips on seeking feedback and using networks
Christina Sherwood
4/2/2013
Blog Resource
Summary:

LUMOback is the first product by LUMO, a Palo Alto-based company founded by three entrepreneurs – including one who suffered back problems for years. Charles Wang, co-founder and CMO, shared what he’s learned since the company’s launch in 2011 and the product’s release last year.

Read More
Bioarray Therapeutics: CEO offers insights on sharing the company’s vision
Christina Sherwood
3/26/2013
Blog Resource
Summary:

The vision at Bioarray Therapeutics, a biotechnology company in Boston, is to improve cancer detection and treatment. By finding genes associated with cancer, the company is developing a diagnostic for breast cancer that can help doctors and patients choose the best treatment.

Read More
Atul Butte: Biotechnology entrepreneur on success and failure
Christina Sherwood
3/19/2013
Blog Resource
Summary:

As a biomedical informatics researcher and biotechnology entrepreneur in the Silicon Valley, Atul Butte has big ideas for the future of life science entrepreneurship. His Butte Lab works to solve genomic medicine problems through new developments in translational bioinformatics.

Read More
Morpheus Medical: Co-founder shares insights on securing funding and managing costs
Christina Sherwood
3/12/2013
Blog Resource
Summary:

With the goal of revolutionizing cardiac MRI, Morpheus Medical has developed software that takes the process from three hours to about 20 minutes. The company was launched about a year and a half ago when entrepreneurs who wanted to use computational processing to help with the diagnosis of disease came together with radiologists from Stanford University to commercialize the product.

Read More
Weekly Wisdom from Kauffman: America’s high-growth health and drug companies reside in some unexpected locales
Christina Sherwood
2/28/2013
Blog Resource
Summary:

More than 6 percent of Inc. 500 firms work in the health and drug space, making it the No. 5 industrial sector for these fast-growing companies from 2005 to 2010. But these medical innovators aren’t all concentrated in the Silicon Valley.

Read More
Weekly Wisdom from Kauffman: Breaking Down Barriers to Life Sciences Commercialization
Christina Sherwood
2/21/2013
Blog Resource
Summary:

Because life sciences entrepreneurship thrives on harnessing new technologies, spurring innovation, and growing companies, the Kauffman Foundation met in 2003 with the Panel of Advisors on the Life Sciences to help advance those goals.

Read More